Korro Bio KRRO
NASDAQ KRRO
$13.25 +0.29 (+2.24%)
As of: Aug 21, 2026 · 1:44 PM EDT

Korro Bio (KRRO) Operating Margin Growth (5y) (2024 - 2025)

Korro Bio (KRRO) Operating Margin Growth (5y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.59 Bn 131.73 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.21 Bn 78.22 Bn 3.93 Bn
3 Argenx Se 65.65 Bn 60.47 Bn 1.37 Bn
4 Moderna 57.67 Bn 52.53 Bn 52.00 Mn
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 27.90 Bn 9.51 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 Korro Bio 233.44 Mn 118.41 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -379,733.00
Sep 30, 2025 -171,669.00
Jun 30, 2025 -179,041.00
Mar 31, 2025 -90,333.00
Dec 31, 2024 -87,675.00